期刊文献+

喉癌患者血清中血管内皮抑素和血管内皮生长因子的表达及与临床病理特点的关系 被引量:10

下载PDF
导出
摘要 目的观察喉癌患者在手术前后血清中的血管内皮抑素(Endostatin)及血管内皮生长因子(VEGF)水平的变化,分析其与喉癌病理特征的关系。方法用ELISA法检测45例喉癌患者手术前、后血清中Endostatin和VEGF的水平变化,用15例声带息肉患者作对照。结果 (1)喉癌患者术前血清Endostatin水平[(22.83±3.57)μg/L]和VEGF水平[(2.67±0.35)μg/L]均显著高于声带息肉患者[(17.65±3.64)μg/L与(1.03±0.58)μg/L](P<0.01)。(2)喉癌患者术前血清Endostatin和VEGF水平与喉癌的临床分期、肿瘤分化程度、有无淋巴结转移等有关(P<0.05),与患者的性别、年龄、肿瘤生长部位等无关(P>0.05)。(3)喉癌患者术后10 d血清Endostatin水平[(26.38±5.10)μg/L]显著高于术前[(22.83±3.57)μg/L](P<0.05);术后10 d血清VEGF水平[(4.83±0.69)μg/L]显著高于术前[(2.67±0.35)μg/L](P<0.001)。(4)喉癌患者术前血清Endostatin水平与VEGF水平呈负相关(r=-0.784,P<0.01)。结论喉癌患者Endostatin和VEGF的血清水平有明显相关性,在喉癌的发生、浸润和转移中具有重要作用。检测血清中Endostatin、VEGF水平可作为评估喉癌预后的重要指标。
出处 《广东医学》 CAS CSCD 北大核心 2014年第5期717-719,共3页 Guangdong Medical Journal
基金 山东省科技发展计划项目(编号:2012YD18065)
  • 相关文献

参考文献16

  • 1SUNSHINE S B, DALLABRIDA S M, DURAND E. Endostatinlowers blood pressure via nitric oxide and prevents hypertension as- sociated with VEGF inhibition [ J ]. Proc Nail Acad Sci U S A, 2012, 109(28) : 11306 -11311.
  • 2YAMAGUCHI N, ANAND APTE B, LEE M, et al. Endostatin inhibits VEGF - induced endothelial cell migration and tumor growth independently of zinc binding [ J ]. EMBO J, 1999, 18 (16) : 4414 -4423.
  • 3HANAI J, DHANABAL M, KARUMANCHI S A, et al. Endosta- tin causes G1 arrest of endothelial cells through inhibition of cyclin DI[J]. J Biol Chem, 2002, 277(19) : 16464 -16469.
  • 4DVORAK H F, NAGY J A, FENG D, et ah Vascular permeabili- ty factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis[ J]. Curt Top Mi- crobiol Immunol, 1999, 237 : 97 - 132.
  • 5NAGY J A, VASILE E, FENG D, et al. VEGF - A induces an- giogenesis, arteriogenesis, lymphangiogenesis, and vascular mal- formations[ J]. Cold Spring Harb Symp Quant Biol, 2002, 67: 227 - 237.
  • 6PETTERSSON A, NAGY J A, BROWN L F, et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor [J]. Lab Invest, 2000, 80(1):99-115.
  • 7PETTERSSON A, NAGY J A, BROWN L F, et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor [J]. Lab Invest, 2000, 80(1):99-115.
  • 8HAJITOU A, GRIGNET C, DEVY L, et al. The antitumoral effect of endostatin and angiostatin is associated with a down - regu-lation of vascular endothelial growth factor expression in tumor cells[ J]. Faseb J, 2002, 16(13) : 1802 -1804.
  • 9BERGERS G, BENJAMIN L E. Tumorigenesis and the angiogenic switch[J]. Nat Rev Cancer, 2003, 3(6): 401 -410.
  • 10TADDEI L, CHIARUGI P, BROGELLI L, et al. Inhibitory effect of full- length human endostatin on in vitro angiogenesis [ J ]. Bioehem Biophys Res Commun, 1999, 263 (2) : 340 -345.

同被引文献70

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部